← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 8, 2018Last known activity
Mar 1, 2020
Acquired by Shanghai CP Guojian Pharmaceutical Co.,Ltd. on Nov 20, 2015
Timeline
1990s
- Jun 1, 1993
3SBio— Founded
2010s
- Jan 26, 2015
Sirton Pharmaceuticals— Acquired
- Jul 31, 2015
Zhejiang Wansheng Pharmaceutical— Acquired
- Nov 20, 2015
Shanghai CP Guojian Pharmaceutical Co.,Ltd.— Acquired By
- Sep 3, 2017
Therapure Biopharma— Acquired
Drugs by trial phase (3 distinct, 4 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Indications
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (2)
- NCT04231292Lead sponsorPhase 2Mar 1, 2020
- NCT03657238Lead sponsorPhase 1Apr 8, 2018
Details
- Founded
- Shenyang, CN Jun 1, 1993
- Last known activity
- Mar 1, 2020